Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome

NCT00152100 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Severe Combined Immunodeficiency

Interventions

PROCEDURE: Stem cell transplant
DRUG: Filgrastim, Alemtuzumab
DEVICE: Miltenyi CliniMACS

Sponsor

St. Jude Children's Research Hospital